Abstract
Background Currently, the concept of pain is widely discussed in the scientific community, particularly chronic musculoskeletal pain.
One important classification concerns the mechanisms of pain generation, according to which pain is divided into nociceptive pain, neuropathic pain, nociplastic pain (NP), and central sensitization (CS).
Often the terms nociplastic pain and central sensitization are used incorrectly, as synonyms, or improperly; this can make data transmission complicated.
The aim of this review will be to provide a clearer overview of the concept of pain in the scientific literature, describe the variability on the use of the terms nociplastic pain and central sensitization, and describe the mechanisms in relation to musculoskeletal pain syndromes.
Inclusion Criteria Every study describing the mechanisms of nociplastic pain or central sensitization in a population of adults (> 18 years old), with acute or chronic musculoskeletal pain, in one or more anatomic regions. This scoping review will consider studies conducted in any context. Articles in English or Italian will be considered.
Methods The proposed scoping review will be conducted in accordance with the Joanna Briggs Institute methodology (JBI) for scoping reviews.
The search will be carried out on 5 databases: MEDLINE, Cochrane Central, Scopus, Embase, and PEDro.
Selection and data extraction will be conducted by two blind independent researchers and inconsistencies will be resolved by a third reviewer.
The results will be presented in a schematic, tabular and descriptive format that will line up with the objectives and scope of the review.
Conclusions This will be the first scoping review to provide a comprehensive overview of the topic. The results will add meaningful information for clinicians. Furthermore, any knowledge gaps of the topic will be identified. The results of this research will be published in a peer-reviewed journal and will be presented at relevant (inter)national scientific events.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.